Department of Chemistry, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA.
J Am Chem Soc. 2010 Apr 14;132(14):5004-5. doi: 10.1021/ja101372c.
DNA damage is a source of carcinogenicity and is also the source of the cytotoxicity of gamma-radiolysis and antitumor agents, such as the enediynes. The dioxobutane lesion (DOB) is produced by a variety of DNA-damaging agents, including the aforementioned. Repair of DOB is important for maintaining the integrity of the genome as well as counteracting therapeutic agents that target DNA. We demonstrate that the DOB lesion efficiently and irreversibly inhibits repair by DNA polymerase beta (Pol beta), an integral enzyme in base-excision repair. Irreversible inhibition of Pol beta by DOB suggests that this lesion provides a chemical explanation for the cytotoxicity of drugs that produce it and explains previously unexplained observations in the literature concerning abasic lesions that are not repaired efficiently. Finally, these observations provide the impetus for the design of a new family of inhibitors of Pol beta.
DNA 损伤是致癌性的根源,也是γ辐射分解和抗肿瘤药物(如烯二炔类)细胞毒性的根源。二氧丁烷损伤(DOB)是由多种 DNA 损伤剂产生的,包括上述物质。修复 DOB 对于维持基因组的完整性以及对抗以 DNA 为靶点的治疗药物非常重要。我们证明 DOB 损伤能够有效地不可逆地抑制 DNA 聚合酶β(Polβ)的修复,Polβ 是碱基切除修复中的一种必需酶。DOB 对 Polβ 的不可逆抑制表明,这种损伤为产生它的药物的细胞毒性提供了一种化学解释,并解释了文献中以前无法解释的关于未被有效修复的无碱基损伤的观察结果。最后,这些观察结果为设计新型 Polβ 抑制剂家族提供了动力。